000120235 001__ 120235
000120235 005__ 20240319081025.0
000120235 0247_ $$2doi$$a10.3390/jcm11226716
000120235 0248_ $$2sideral$$a131148
000120235 037__ $$aART-2022-131148
000120235 041__ $$aeng
000120235 100__ $$aCabanillas-Barea, Sara
000120235 245__ $$aThe Addition of Diacutaneous Fibrolysis to a Pharmacological Intervention in Patients with Tension-Type Headache: A Randomized Controlled Trial
000120235 260__ $$c2022
000120235 5060_ $$aAccess copy available to the general public$$fUnrestricted
000120235 5203_ $$aBackground: Tension-type headache (TTH) is the most common headache worldwide. Pharmacological interventions are the most investigated therapies in patients with TTH. The addition of physical therapy treatments such as diacutaneous fibrolysis (DF) may have promising results. The aim of this study was to investigate the addition of three sessions of DF to a pharmacological intervention in patients with TTH. Methods: A single-blinded randomized controlled trial was carried out. Participants were randomly assigned to the standard care group or to the DF group. Both groups received a pharmacological intervention. Three sessions of DF in the thoracic and cervicocranial region were added in the DF group. The impact caused by headache (HIT-6), headache intensity, and cervical range of motion were measured by blinded assessors at baseline, after the intervention, and at 1 month follow-up. Results: Eighty-two patients with TTH were included (41 standard care group; 41 DF group). Statistically significant differences were found between both groups in all the variables after the intervention and at 1 month follow-up (p < 0.001). No adverse effects or side-effects were reported during the study. Conclusions: The addition of three sessions of DF to a pharmacological therapy provided improvements in the impact caused by headache, headache intensity, and cervical range of motion after the intervention and at 1 month follow-up compared to a pharmacological therapy in isolation. Further research is needed to investigate long-term effects.
000120235 540__ $$9info:eu-repo/semantics/openAccess$$aby$$uhttp://creativecommons.org/licenses/by/3.0/es/
000120235 590__ $$a3.9$$b2022
000120235 592__ $$a0.935$$b2022
000120235 591__ $$aMEDICINE, GENERAL & INTERNAL$$b58 / 169 = 0.343$$c2022$$dQ2$$eT2
000120235 593__ $$aMedicine (miscellaneous)$$c2022$$dQ1
000120235 594__ $$a5.4$$b2022
000120235 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000120235 700__ $$aCeballos-Laita, Luis$$uUniversidad de Zaragoza
000120235 700__ $$aPérez-Guillén, Silvia
000120235 700__ $$aJiménez-del-Barrio, Sandra
000120235 700__ $$0(orcid)0000-0001-7732-3914$$aPardos-Aguilella, Pilar$$uUniversidad de Zaragoza
000120235 700__ $$aRodríguez-Rubio, Pere Ramón
000120235 700__ $$aCarrasco-Uribarren, Andoni
000120235 7102_ $$11006$$2413$$aUniversidad de Zaragoza$$bDpto. Fisiatría y Enfermería$$cÁrea Fisioterapia
000120235 773__ $$g11, 22 (2022), 6716 [11 pp.]$$pJ. clin.med.$$tJournal of Clinical Medicine$$x2077-0383
000120235 8564_ $$s1077900$$uhttps://zaguan.unizar.es/record/120235/files/texto_completo.pdf$$yVersión publicada
000120235 8564_ $$s2814008$$uhttps://zaguan.unizar.es/record/120235/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000120235 909CO $$ooai:zaguan.unizar.es:120235$$particulos$$pdriver
000120235 951__ $$a2024-03-18-16:38:48
000120235 980__ $$aARTICLE